Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
2.
Congenit Heart Dis ; 11(6): 578-583, 2016 Dec.
Article En | MEDLINE | ID: mdl-27030521

OBJECTIVE: Atrial tachyarrhythmias frequently develop after the Fontan operation. Patients with Fontan physiology rely on atrial contribution to cardiac output, and thus control of atrial arrhythmias is important. Outcomes after cardioversion in patients after Fontan have not been reported. We sought to determine if cardioversion results in improved echocardiographic parameters or clinical symptomatology; and, discern risk factors for arrhythmia recurrence. DESIGN: We retrospectively analyzed the Mayo Clinic echocardiographic database to capture patients after the Fontan operation who underwent transesophageal echocardiography-guided electrical cardioversion from 2000-2015. Clinical and echocardiographic data were collected and compared at baseline and follow-up. RESULTS: Eight hundred ninety patients with prior Fontan operation underwent echocardiographic evaluation; 341 (38%) developed atrial arrhythmias. Thirty-six patients [20 males, median age 29 (12-51)] underwent transesophageal echocardiography-guided cardioversion of atrial arrhythmias [atrial flutter/intraatrial reentrant tachycardia (75%); atrial fibrillation (25%)]. At follow-up, improvements were noted in ejection fraction by 10% (P < .0001); atrioventricular valve regurgitation grade (39%) (P = .002); New York Heart Association (NYHA) class (61%) (P < .001); and resolution of spontaneous echo contrast in the Fontan circuit (65%) (P < .01). No embolic events occurred following cardioversion. Eighteen patients (50%) developed recurrent atrial arrhythmias at 15 (3-36) months after cardioversion. Five-year freedom from arrhythmia recurrence was 61%. Significant univariate predictors of arrhythmia recurrence were atrial flutter/intraatrial reentrant tachycardia (HR = 4.3, P = .02); NYHA ≥ II (HR = 4.1, P = .03); systemic right ventricle (HR = 5.2; P = .02); and ejection fraction ≤ 40% (HR = 2.8; P = .04). On multivariate analysis, only systemic right ventricle (HR = 3.7; P = .02) remained an independent predictor of arrhythmia recurrence. CONCLUSION: After the Fontan operation, cardioversion of atrial arrhythmias improves ventricular function, atrioventricular valve regurgitation grade, and NYHA class. Arrhythmia recurrence was common and patients with atrial flutter/intraatrial reentrant tachycardia, systemic right ventricle, or reduced ventricular function may be at risk of arrhythmia recurrence. Further studies are required to identify additional risk factors and protective factors for arrhythmia recurrence.


Atrial Fibrillation/therapy , Atrial Flutter/therapy , Echocardiography, Transesophageal , Electric Countershock/methods , Fontan Procedure/adverse effects , Heart Defects, Congenital/surgery , Tachycardia, Reciprocating/therapy , Ventricular Function, Left , Ventricular Function, Right , Adolescent , Adult , Atrial Fibrillation/diagnostic imaging , Atrial Fibrillation/etiology , Atrial Fibrillation/physiopathology , Atrial Flutter/diagnostic imaging , Atrial Flutter/etiology , Atrial Flutter/physiopathology , Child , Databases, Factual , Disease-Free Survival , Electric Countershock/adverse effects , Female , Heart Defects, Congenital/diagnosis , Heart Defects, Congenital/physiopathology , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Minnesota , Predictive Value of Tests , Recovery of Function , Recurrence , Retrospective Studies , Risk Factors , Tachycardia, Reciprocating/diagnostic imaging , Tachycardia, Reciprocating/etiology , Tachycardia, Reciprocating/physiopathology , Time Factors , Treatment Outcome , Young Adult
3.
Cardiol Young ; 22(5): 606-9, 2012 Oct.
Article En | MEDLINE | ID: mdl-22398140

A 34-week premature neonate presented with drug-refractory permanent junctional incessant tachycardia and haemodynamic compromise. The patient underwent successful radiofrequency catheter ablation using a single-catheter approach. The child remains in sinus rhythm, without pharmacological treatment, 2 years after the procedure.


Catheter Ablation/instrumentation , Heart Conduction System/surgery , Infant, Premature , Tachycardia, Reciprocating/surgery , Electrocardiography , Equipment Design , Female , Follow-Up Studies , Heart Conduction System/physiopathology , Heart Rate , Humans , Infant, Newborn , Pregnancy , Tachycardia, Reciprocating/diagnostic imaging , Tachycardia, Reciprocating/physiopathology , Ultrasonography, Prenatal , Young Adult
4.
Ultrasound Obstet Gynecol ; 33(5): 595-8, 2009 May.
Article En | MEDLINE | ID: mdl-19402102

Ultrasound examination of a fetus at 32 weeks' gestation revealed dilated cardiomyopathy and a heart rate of 170 beats per minute. Prenatally, this mild tachycardia was not primarily suspected to be the cause of the myocardial changes. Postnatal electrocardiography revealed a persistent junctional reciprocating tachycardia (PJRT) and the diagnosis of tachycardia-induced cardiomyopathy (TICM) became apparent. After conversion to a sinus rhythm under digoxin and amiodarone, the cardiac changes regressed. PJRT is a rare form of supraventricular tachycardia. The prenatal findings in the condition have previously been described retrospectively, but it can only be diagnosed postnatally by its characteristic electrocardiographic properties. This case indicates that TICM can occur at lower heart rates than previously assumed. Even severe prenatal cardiomyopathy may be reversible once sinus rhythm has been restored.


Cardiomyopathy, Dilated/etiology , Fetal Diseases , Tachycardia, Reciprocating/complications , Adult , Amiodarone/administration & dosage , Anti-Arrhythmia Agents/administration & dosage , Blood Flow Velocity/physiology , Cardiomyopathy, Dilated/diagnostic imaging , Digoxin/administration & dosage , Drug Therapy, Combination , Female , Fetal Diseases/diagnostic imaging , Gestational Age , Heart Rate, Fetal/drug effects , Heart Rate, Fetal/physiology , Humans , Infant, Newborn , Male , Pregnancy , Tachycardia, Reciprocating/diagnostic imaging , Tachycardia, Reciprocating/drug therapy , Ultrasonography, Prenatal
...